Mapping Disease Pathways for Biliary Atresia

Launched by UNIVERSITY OF PITTSBURGH · Sep 1, 2017

Keywords

ClinConnect Summary

This clinical trial, titled "Mapping Disease Pathways for Biliary Atresia," is focused on understanding the causes and development of biliary atresia, a serious liver condition that is the leading cause of liver failure in newborns. The study aims to investigate the genetic and developmental factors related to this condition, which affects many children and often leads to liver transplants. Researchers are currently looking for participants who have been diagnosed with biliary atresia and are scheduled to receive a liver transplant from one of several hospitals involved in the study.

Eligible participants include children who have been diagnosed with biliary atresia and are receiving care at specific hospitals, such as Children's Hospital of Pittsburgh and Kings College Hospital. However, the study will not include children under the care of the state or those with temporary guardians. If you or your child takes part in this trial, you can expect to contribute to important research that may help improve understanding and treatment options for biliary atresia in the future. Overall, this study aims to make a difference in the lives of children affected by this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • living individuals who were diagnosed with Biliary Atresia and received or are about to receive a liver transplant from multiple participating centers (Children's Hospital of Pittsburgh, Kings College Hospital, Children's Hospital of Birmingham, and Hospital Sírio-Libanês).
• Exclusion Criteria:
• • No child participant in the care of the state will be enrolled, nor will patients in the care of temporary or informal guardians be enrolled